LOCKHART B. MCGUIRE, M.D.; LAY M. FOX, M.D.
The presence of pheochromocytoma can be recognized with increasing reliability through the measurement of urinary and blood levels of the catecholamines and their metabolites, in addition to the standard histamine and phentolamine infusion tests (1, 2). Greater portions of the circulating hormones are excreted as 3-methoxy-4-hydroxymandelic acid (VMA), than as epinephrine and norepinephrine. Thus, the measurement of urinary VMA has become widely used to detect high circulating levels of these hormones (3). However, once the presence of such a tumor has been established, the problem of localizing it for the purposes of surgical removal may be a major one. According
MCGUIRE LB, FOX LM. Recurrent Pheochromocytoma with Recognition of Site of Metastasis by Means of Venous Catheterization: A Case Study. Ann Intern Med. 1964;60:125–130. doi: https://doi.org/10.7326/0003-4819-60-1-125
Download citation file:
Published: Ann Intern Med. 1964;60(1):125-130.
Adrenal Disorders, Endocrine and Metabolism, Endocrine Cancer, Hematology/Oncology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use